$
2. 82
-0.02
-0.7042%
$
139.98M Market Cap
- P/E Ratio
- Div Yield
99,997 Volume
-0.32 Eps
$ 2.84
Previous Close 
Want to track ENTX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Entera Bio Ltd. (ENTX) Statistics
Valuation metrics
Market Cap 139.98M
Enterprise value 129.1M
Trailing P/E (ttm) -8.19
Forward P/E -2.4
PEG ratio 0.06
Price/Sales (ttm) 1,547.08
Price/Book (mrq) 19.72
Enterprise Value/Revenue 1,285.5
Enterprise Value/EBITDA -9.05
Overview
Shares outstanding 46.18M
Float 32.24M
Shares short 192.78K
% Held by insiders 0.21%
% Held by institutions 0.17%
Average volume (10 days) 170.8K
Average volume (90 days) 5.1M
Price summary
52-Week low 0.91
52-Week high 4.2
Beta 1.55
50-Day moving average 2.97
200-Day moving average 1.53
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Dec 2025
Profitability
Profit margin 0.05%
Operating margin -274.5%
Operational effectiveness
Return on assets -0.87%
Return on equity -1.47%
Income Statement
Revenue (ttm) 42K
Revenue per share (ttm) 0
Quarterly revenue growth (yoy) -1%
Gross profit (ttm) 9K
EBITDA -11.5M
Net income to common (ttm) -11.44M
Diluted EPS (ttm) -0.34
Quarterly earnings growth (yoy) -1%
Balance Sheet
Total cash (mrq) 7.11M
Total cash per share (mrq) 0.22
Total debt (mrq) 490K
Total Debt/Equity (mrq) 0.06
Current ratio (mrq) 8.98%
Book value per share (mrq) 0.14
Cash Flow
Cash flow statement -7.37M
Levered free cash flow (LFCF) -11.44M
